SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.

(SQM)
  Report
Delayed Nyse  -  05/20 04:00:01 pm EDT
95.46 USD   +0.24%
05/20Deutsche Bank Adjusts Sociedad Quimica y Minera de Chile Price Target to $122 From $98, Maintains Buy Rating
MT
05/20Citigroup Adjusts Price Target on Sociedad Quimica y Minera de Chile to $121 From $103, Keeps Buy Rating
MT
05/19TRANSCRIPT : Sociedad Química y Minera de Chile S.A., Q1 2022 Earnings Call, May 19, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sociedad Química y Minera de Chile S.A. : A medium term support level to take advantage of

01/05/2022 | 08:41am EDT
long trade
Target price hit
Entry price : 49.75$ | Target : 71.44$ | Stop-loss : 45$ | Potential : 43.6%
The support at 46.59 USD, which is currently being tested, should allow Sociedad Química y Minera de Chile S.A. shares to move back to the upside.
Investors have an opportunity to buy the stock and target the $ 71.44.
Sociedad Química y Minera de Chile S.A. : Sociedad Química y Minera de Chile S.A. : A medium term support level to take advantage of
Summary
  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths
  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For the past twelve months, EPS forecast has been revised upwards.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses
  • With an expected P/E ratio at 30.6 and 16.45 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • The company appears highly valued given the size of its balance sheet.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
  • The group usually releases earnings worse than estimated.

© MarketScreener.com 2022

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (USD)
Sales 2022 8 821 M - -
Net income 2022 3 308 M - -
Net Debt 2022 1 644 M - -
P/E ratio 2022 8,24x
Yield 2022 5,50%
Capitalization 27 267 M 27 267 M -
EV / Sales 2022 3,28x
EV / Sales 2023 4,12x
Nbr of Employees 6 081
Free-Float 99,7%
Upcoming event on SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Last Close Price 95,46 $
Average target price 96,93 $
Spread / Average Target 1,54%
EPS Revisions
Managers and Directors
Ricardo Ramos Rodríguez Chief Executive Officer
Gerardo Andrés Illanes González Chief Financial Officer
Gonzalo Guerrero Yamamoto Chairman
José Francisco Sánchez Figueroa Risk Management & Compliance Officer
Ashley Luke Ozols Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.89.29%27 267
PJSC PHOSAGRO27.72%15 540
ICL GROUP LTD26.22%14 686
UPL LIMITED8.17%7 794
YUNNAN YUNTIANHUA CO., LTD.33.13%7 165
K+S AG89.60%5 813